Microrna mir-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling

Journal of Cell Science

Volumn 126, Issue 6, 2013, Pages 1440-1453

  Du, William W ^a,b   Fang, Ling ^a,b   Li, Minhui ^a,b,c   Yang, Xiangling ^a,b   Liang, Yaoyun ^d   Peng, Chun ^a,d   Qian, Wei ^e   O'Malley, Yunxia Q ^f   Askeland, Ryan W ^f   Sugg, Sonia L ^f   Qian, Jun ^e   Lin, Jiang ^e   Jiang, Zide ^c   Yee, Albert J ^a   Sefton, Michael ^a   Deng, Zhaoqun ^a,b   Shan, Sze Wan ^a,b   Wang, Chia Hui ^a,b   Yang, Burton B ^a,b  

^a Sunnybrook Health Sciences Centre   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^d YORK UNIVERSITY   (Canada)

^e AFFILIATED PEOPLE S HOSPITAL OF JIANGSU UNIVERSITY   (China)

^f UNIVERSITY OF IOWA   (United States)

Author keywords

Metastasis; Microrna; Mir 24; PEGFR; Tumor invasion

Indexed keywords

ADAM PROTEIN; ADAM15 PROTEIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; MICRORNA 24; MITOGEN ACTIVATED PROTEIN KINASE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE; PHOSPHATASE TYROSINE PHOSPHATASE NON RECEPTOR TYPE 9; PROTEIN TYROSINE PHOSPHATASE; RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASE F; STROMELYSIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST; BREAST CARCINOMA; BREAST METASTASIS; CANCER CELL; CANCER PATIENT; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; LUNG PARENCHYMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR INVASION; TUMOR XENOGRAFT;

METASTASIS; MICRORNA; MIR-24; PEGFR; TUMOR INVASION;

ANIMALS; BREAST NEOPLASMS; CELL GROWTH PROCESSES; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MICE; MICE, INBRED BALB C; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 2; SIGNAL TRANSDUCTION; TRANSGENES;

EID: 84877899547     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.118299     Document Type: Article

References (56)

1. Arora, A. and Simpson, D. A. (2008). Individual mRNA expression profiles reveal the effects of specific microRNAs. Genome Biol. 9, R82.
2. Aslakson, C. J. and Miller, F. R. (1992). Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 52, 1399-1405.
3. Deng, M., Tang, H., Zhou, Y., Zhou, M., Xiong, W., Zheng, Y., Ye, Q., Zeng, X., Liao, Q., Guo, X. et al. (2011). miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma. J. Cell Sci. 124, 2997-3005.
4. Deng, Z., Du, W. W., Fang, L., Shan, S. W., Qian, J., Lin, J., Qian, W., Ma, J., Rutnam, Z. J. and Yang, B. B. (2013). The intermediate filament vimentin mediates microRNA miR-378 function in cellular self-renewal by regulating the expression of the Sox2 transcription factor. J. Biol. Chem. 288, 319-331
5. Fang, L., Deng, Z., Shatseva, T., Yang, J., Peng, C., Du, W. W., Yee, A. J., Ang, L. C., He, C., Shan, S. W. et al. (2011). MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-b8. Oncogene 30, 806-821.
6. Fang, L., Du, W. W., Yang, W., Rutnam, Z. J., Peng, C., Li, H., O'Malley, Y. Q., Askeland, R. W., Sugg, S., Liu, M. et al. (2012a). MiR-93 enhances angiogenesis and metastasis by targeting LATS2. Cell Cycle 11, 4352-4365.
7. Fang, L., Du, W. W., Yang, X., Chen, K., Ghanekar, A., Levy, G., Yang, W., Yee, A. J., Lu, W. Y., Xuan, J. W. et al. (2012b). Versican 39-untranslated region (39-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity. FASEB J. [Epub ahead of print] doi: 10.1096/fj.12-220905 fj.12-220905
8. Goljanek-Whysall, K., Pais, H., Rathjen, T., Sweetman, D., Dalmay, T. and Münsterberg, A. (2012). Regulation of multiple target genes by miR-1 and miR-206 is pivotal for C2C12 myoblast differentiation. J. Cell Sci. 125, 3590-3600.
9. Gong, M., Meng, L., Jiang, B., Zhang, J., Yang, H., Wu, J. and Shou, C. (2008). p37 from Mycoplasma hyorhinis promotes cancer cell invasiveness and metastasis through activation of MMP-2 and followed by phosphorylation of EGFR. Mol. Cancer Ther. 7, 530-537.
10. Huang, Q., Gumireddy, K., Schrier, M., le Sage, C., Nagel, R., Nair, S., Egan, D. A., Li, A., Huang, G., Klein-Szanto, A. J. et al. (2008). The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat. Cell Biol. 10, 202-210.
11. Huynh, H., Bottini, N., Williams, S., Cherepanov, V., Musumeci, L., Saito, K., Bruckner, S., Vachon, E., Wang, X., Kruger, J. et al. (2004). Control of vesicle fusion by a tyrosine phosphatase. Nat. Cell Biol. 6, 831-839.
12. Jeyapalan, Z., Deng, Z., Shatseva, T., Fang, L., He, C. and Yang, B. B. (2011). Expression of CD44 39-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis. Nucleic Acids Res. 39, 3026-3041.
13. Kahai, S., Lee, S. C., Lee, D. Y., Yang, J., Li, M., Wang, C. H., Jiang, Z., Zhang, Y., Peng, C. and Yang, B. B. (2009). MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7. PLoS ONE 4, e7535.
14. Koletsa, T., Kotoula, V., Karayannopoulou, G., Nenopoulou, E., Karkavelas, G., Papadimitriou, C. S. and Kostopoulos, I. (2010). EGFR expression and activation are common in HER2 positive and triple-negative breast tumours. Histol. Histopathol. 25, 1171-1179.
15. Lagos-Quintana, M., Rauhut, R., Lendeckel, W. and Tuschl, T. (2001). Identification of novel genes coding for small expressed RNAs. Science 294, 853-858.
16. Lal, A., Kim, H. H., Abdelmohsen, K., Kuwano, Y., Pullmann, R., Jr., Srikantan, S., Subrahmanyam, R., Martindale, J. L., Yang, X., Ahmed, F. et al. (2008). p16(INK4a) translation suppressed by miR-24. PLoS ONE 3, e1864. doi:10.1371/ journal.pone.0001864
17. Lal, A., Navarro, F., Maher, C. A., Maliszewski, L. E., Yan, N., O'Day, E., Chowdhury, D., Dykxhoorn, D. M., Tsai, P., Hofmann, O. et al. (2009). miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless"3'UTR microRNA recognition elements. Mol. Cell 35, 610-625.
18. LaPierre, D. P., Lee, D. Y., Li, S. Z., Xie, Y. Z., Zhong, L., Sheng, W., Deng, Z. and Yang, B. B. (2007). The ability of versican to simultaneously cause apoptotic resistance and sensitivity. Cancer Res. 67, 4742-4750.
19. Lee, D. Y., Deng, Z., Wang, C. H. and Yang, B. B. (2007). MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc. Natl. Acad. Sci. USA 104, 20350-20355.
20. Lee, D. Y., Shatseva, T., Jeyapalan, Z., Du, W. W., Deng, Z. and Yang, B. B. (2009). A 3'-untranslated region (3'UTR) induces organ adhesion by regulating miR-199az* functions. PLoS ONE 4, e4527.
21. Lin, S. C., Liu, C. J., Lin, J. A., Chiang, W. F., Hung, P. S. and Chang, K. W. (2010). miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis. Oral Oncol. 46, 204-208.
22. Luo, L., Ye, G., Nadeem, L., Fu, G., Yang, B. B., Honarparvar, E., Dunk, C., Lye, S. and Peng, C. (2012). MicroRNA-378a-5p promotes trophoblast cell survival, migration and invasion by targeting Nodal. J. Cell Sci. 125, 3124-3132.
23. Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S.,Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G. et al. (2004). Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 350, 2129-2139.
24. Ma, L., Teruya-Feldstein, J. and Weinberg, R. A. (2007). Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449, 682-688.
25. Magkou, C., Nakopoulou, L., Zoubouli, C., Karali, K., Theohari, I., Bakarakos, P. and Giannopoulou, I. (2008). Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas. Breast Cancer Res. 10, R49.
26. Naundorf, H., Rewasowa, E. C., Fichtner, I., Büttner, B., Becker, M. and Görlich, M. (1992). Characterization of two human mammary carcinomas, MT-1 and MT-3, suitable for in vivo testing of ether lipids and their derivatives. Breast Cancer Res. Treat. 23, 87-95.
27. Nohata, N., Hanazawa, T., Enokida, H. and Seki, N. (2012). microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers. Oncotarget 3, 9-21.
28. Qian, L., Van Laake, L. W., Huang, Y., Liu, S., Wendland, M. F. and Srivastava, D. (2011). miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J. Exp. Med. 208, 549-560.
29. Qin, W., Shi, Y., Zhao, B., Yao, C., Jin, L., Ma, J. and Jin, Y. (2010). miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells. PLoS ONE 5, e9429.
30. Rutnam, Z. J. and Yang, B. B. (2012a). The involvement of microRNAs in malignant transformation. Histol. Histopathol. 27, 1263-1270.
31. Rutnam, Z. J. and Yang, B. B. (2012b). The non-coding 39 UTR of CD44 induces metastasis by regulating extracellular matrix functions. J. Cell Sci. 125, 2075-2085.
32. Schmidt-Ullrich, R. K., Mikkelsen, R. B., Dent, P., Todd, D. G., Valerie, K., Kavanagh, B. D., Contessa, J. N., Rorrer, W. K. and Chen, P. B. (1997). Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene 15, 1191-1197.
33. Seitz, H., Youngson, N., Lin, S. P., Dalbert, S., Paulsen, M., Bachellerie, J. P., Ferguson-Smith, A. C. and Cavaillé, J. (2003). Imprinted microRNA genes transcribed antisense to a reciprocally imprinted retrotransposon-like gene. Nat. Genet. 34, 261-262.
34. Shan, S. W., Lee, D. Y., Deng, Z., Shatseva, T., Jeyapalan, Z., Du, W. W., Zhang, Y., Xuan, J. W., Yee, S. P., Siragam, V. et al. (2009). MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Nat. Cell Biol. 11, 1031-1038.
35. Shan, S. W., Fang, L., Shatseva, T., Rutnam, Z. J., Yang, X., Du, W. W., Lu, W.-Y., Xuan, J. W., Deng, Z. and Yang, B. B. (2013). Mature miR-17-5p and passenger miR-17-3p induce hepatocellular carcinoma by targeting PTEN, GalNT7 and vimentin in different signal pathways. J. Cell Sci. 126, 1517-1530.
36. Shatseva, T., Lee, D. Y., Deng, Z. and Yang, B. B. (2011). MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2. J. Cell Sci. 124, 2826-2836.
37. Siragam, V., Rutnam, Z. J., Yang, W., Fang, L., Luo, L., Yang, X., Li, M., Deng, Z., Qian, J., Peng, C. et al. (2012). MicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11. Oncotarget 3, 1370-1385.
38. Smits, M., Nilsson, J., Mir, S. E., van der Stoop, P. M., Hulleman, E., Niers, J. M., de Witt Hamer, P. C., Marquez, V. E., Cloos, J., Krichevsky, A. M. et al. (2010). miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis. Oncotarget 1, 710-720.
39. Song, L. and Tuan, R. S. (2006). MicroRNAs and cell differentiation in mammalian development. Birth Defects Res. C Embryo Today 78, 140-149.
40. Sørensen, O. E., Thapa, D. R., Roupé, K. M., Valore, E. V., Sjöbring, U., Roberts, A. A., Schmidtchen, A. and Ganz, T. (2006). Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor. J. Clin. Invest. 116, 1878-1885.
41. Swanton, C., Szallasi, Z., Brenton, J. D. and Downward, J. (2008). Functional genomic analysis of drug sensitivity pathways to guide adjuvant strategies in breast cancer. Breast Cancer Res. 10, 214.
42. Tonks, N. K. (2006). Protein tyrosine phosphatases: from genes, to function, to disease. Nat. Rev. Mol. Cell Biol. 7, 833-846.
43. Viticchiè, G., Lena, A. M., Latina, A., Formosa, A., Gregersen, L. H., Lund, A. H., Bernardini, S., Mauriello, A., Miano, R., Spagnoli, L. G. et al. (2011). MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines. Cell Cycle 10, 1121-1131.
44. Volinia,S., Calin, G.A.,Liu, C. G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M. et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 103, 2257-2261.
45. Walker, F., Abramowitz, L., Benabderrahmane, D., Duval, X., Descatoire, V., Hénin, D., Lehy, T. and Aparicio, T. (2009). Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus. Hum. Pathol. 40, 1517-1527.
46. Wang, C. H., Lee, D. Y., Deng, Z., Jeyapalan, Z., Lee, S. C., Kahai, S., Lu, W. Y., Zhang, Y. and Yang, B. B. (2008a). MicroRNA miR-328 regulates zonation morphogenesis by targeting CD44 expression. PLoS ONE 3, e2420.
47. Wang, X., Tang, S., Le, S. Y., Lu, R., Rader, J. S., Meyers, C. and Zheng, Z. M. (2008b). Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS ONE 3, e2557.
48. Xie, L., Wang, T., Yu, S., Chen, X., Wang, L., Qian, X., Yu, L., Ding, Y., Zhang, C. and Liu, B. (2011). Cell-free miR-24 and miR-30d, potential diagnostic biomarkers in malignant effusions. Clin. Biochem. 44, 216-220.
49. Yang, X., Rutnam, Z. J., Jiao, C., Wei, D., Xie, Y., Du, J., Zhong, L. and Yang, B. B. (2012). An anti-let-7 sponge decoys and decays endogenous let-7 functions. Cell Cycle 11, 3097-3108.
50. Ye, G., Fu, G., Cui, S., Zhao, S., Bernaudo, S., Bai, Y., Ding, Y., Zhang, Y., Yang, B. B. and Peng, C. (2011). MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance. J. Cell Sci. 124, 359-368.
51. Yu, B., Zhou, S., Wang, Y., Qian, T., Ding, G., Ding, F. and Gu, X. (2012). miR-221 and miR-222 promote Schwann cell proliferation and migration by targeting LASS2 after sciatic nerve injury. J. Cell Sci. 125, 2675-2683.
52. Yuan, T., Wang, Y., Zhao, Z. J. and Gu, H. (2010). Protein-tyrosine phosphatase PTPN9 negatively regulates ErbB2 and epidermal growth factor receptor signaling in breast cancer cells. J. Biol. Chem. 285, 14861-14870.
53. Zaidi, S. K., Dowdy, C. R., van Wijnen, A. J., Lian, J. B., Raza, A., Stein, J. L., Croce, C. M. and Stein, G. S. (2009). Altered Runx1 subnuclear targeting enhances myeloid cell proliferation and blocks differentiation by activating a miR-24/MKP-7/ MAPK network. Cancer Res. 69, 8249-8255.
54. Zhang, H., Berezov, A., Wang, Q., Zhang, G., Drebin, J., Murali, R. and Greene, M. I. (2007). ErbB receptors: from oncogenes to targeted cancer therapies. J. Clin. Invest. 117, 2051-2058.
55. Zhu, J. H., Chen, R., Yi, W., Cantin, G. T., Fearns, C., Yang, Y., Yates, J. R., 3rd and Lee, J. D. (2008). Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling. Oncogene 27, 2525-2531.
56. Zou, C., Xu, Q., Mao, F., Li, D., Bian, C., Liu, L. Z., Jiang, Y., Chen, X., Qi, Y., Zhang, X. et al. (2012). MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF. Cell Cycle 11, 2137-2145.